Successful treatment of atrial flutter with amiodarone in a premature neonate: Case report and literature review

Advances in Neonatal Care

Volumn 7, Issue 3, 2007, Pages 113-121

  Knirsch, Walter ^a,b   Kretschmar, Oliver ^b   Vogel, Martin ^c   Uhlemann, Frank ^a   Bauersfeld, Urs ^b  

^a Olgahospital ^*  (Germany)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

amiodarone; atrial flutter; fetal arrhythmia; lung disease; neonate; supraventricular tachycardia

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT;

CASE REPORT; HEART ATRIUM FLUTTER; HUMAN; NEWBORN; PREMATURITY; REVIEW; SUPRAVENTRICULAR TACHYCARDIA;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FLUTTER; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; TACHYCARDIA, SUPRAVENTRICULAR;

EID: 34848915774     PISSN: 15360903     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ANC.0000278209.11015.f7     Document Type: Article

References (47)

1. Figa FH, Gow RM, Hamilton RH, Freedom RM. Clinical efficacy and safety of intravenous amiodarone in infants and children. Am J Cardiol. 1994;74:573-577.
2. Perry JC, Fenrich AL, Hulse JE, Triedman TK, Friedman RA, Lamberti JJ. Pediatric use of intravenous amiodarone: efficacy and safety in critically ill patients from a multicenter protocol. J Am Coll Cardiol. 1996;27:1246-1250.
3. Coumel P, Fidelle J. Amiodarone in the treatment of cardiac arrhythmias in children: one hundred thirty-five cases. Am Heart J. 1980;100:1063-1069.
4. Pongiglione G, Strasburger JF, Deal BJ, Benson DW Jr. Use of amiodarone for short-term and adjuvant therapy in young patients. Am J Cardiol. 1991;68:603-608.
5. Schuler CO, Case CL, Gillette PC. Efficacy and safety of amiodarone in infants. Am Heart J. 1993;125:1430-1432.
6. Drago F, Mazza A, Guccione P, Mafricie A, Di Liso G, Ragonese P. Amiodarone used alone or in combination with propanolol: a very effective therapy for tachyarrhythmias in infants and children. Pediatr Cardiol. 1998;19:445-449.
7. Strasburger JF, Cuneo BF, Michon MM, et al. Amiodarone therapy for drug-refractory fetal tachycardia. Circulation. 2004;109:375-379.
8. Hijazi ZM, Rosenfeld LE, Copel JA, Kleinman CS. Amiodarone therapy of intractable atrial flutter in a premature hydropic neonate. Pediatr Cardiol. 1992;13:227-229.
9. Magee LA, Downar E, Sermer M, Boulton BC, Allen LC, Koren G. Pregnancy outcome after gestational exposure to amiodarone in Canada. Am J Obstet Gynecol. 1995;172:1307-1311.
10. Tubman R, Jenkins J, Lim J. Neonatal hyperthyroxinaemla associated with maternal amiodarone therapy: case report. Ir J Med Sci. 1988;7:243.
11. Burri S, Hug MI, Bauersfeld U. Efficacy and safety of intravenous amiodarone for incessant tachycardias in infants. Eur J Pediatr. 2003;162:880-884.
12. Etheridge SP, Craig JE, Compton SJ. Amiodarone is safe and highly effective therapy for supraventricular tachycardia in infants. Am Heart J. 2001;141:105-110.
13. Vrobel TR, Miller PE, Mostow ND, Rakita L A general overview of amiodarone toxicity: its prevention, detection, and management. Prog Cardiovasc Dis. 1989;31:393-426.
14. Southall DP, Johnson AM, Shinebourne EA, Johnston PG, Vulliamy DG. Frequency and outcome of disorders of cardiac rhythm and conduction in a population of newborn infants. Pediatrics. 1981;68:58-66.
15. Lundberg A. Paroxysmal atrial tachycardia in infancy: long-term follow-up of 49 subjects. Pediatrics. 1982;70:638-642.
16. Dunnigan A, Benson DW, Benditt DG. Atrial flutter in infancy: diagnosis, clinical features, and treatment. Pediatrics. 1985;75:725-729.
17. Garson A Jr, Bink-Boelkens M, Hesslein PS, et al. Atrial flutter in the young: a collaborative study of 380 cases. J Am Coll Cardiol. 1985;6:871-878.
18. Friedman AH, Copel JA, Kleiman CS. Fetal echocardiography and fetal cardiology: indications, diagnosis and management. Semin Perinatal. 1993;17:76-88.
19. Allan LD, Chita SK, Sharland GK, Maxwell D, Priestley K. Flecainide in the treatment of fetal tachycardias. Br Heart J. 1991;65:46-48.
20. Oudijk JA, Michon MM, Kleinman CS, et al. Sotalol in the treatment of fetal dysrhythmias. Circulation. 2000;101:2721-2726.
21. Krapp M, Kohl T, Simpson JM, Sharland GK, Katalinic A, Gembruch U. Review of diagnosis, treatment, and outcome of fetal atrial flutter compared with supraventricular tachycardia. Heart. 2003;89:913-917.
22. Sivakumar S. Atrial flutter in preterm babies. Arch Dis Child Fetal Neonatal Ed. 2004;89:F564.
23. Casey F, McCrindle BW, Hamilton RM, Gow RM. Neonatal atrial flutter: significant early morbidity and excellent long-term prognosis. Am Heart J. 1997;133:302-306.
24. Peng CC, Chen MR, Hou CJ, et al. Atrial flutter in the neonate and early infancy. Jpn Heart J. 1998;39:287-295.
25. Simpson JM, Sharland GK. Fetal tachycardias: management and outcome of 127 consecutive cases. Heart. 1998;79:576-581.
26. Naumburg E, Riesenfeld T, Axelsson O. Fetal tachycardia: intrauterine and postnatal course. Fetal Diagn Ther. 1997;12:205-209.
27. Suzumura H, Nitta A, Ono M, Arisaka O. Neonatal intractable atrial flutter successfully treated with intravenous flecainlde. Pediatr Cardiol. 2004; 25:154-156.
28. Jaeggi E, Fouron JC, Drblik SP. Fetal atrial flutter: diagnosis, clinical features, treatment, and outcome. J Pediatr. 1998;132:335-339.
29. Lisowski LA, Verheijen PM, Benatar AA, et al. Atrial flutter in the perinatal age group: diagnosis, management and outcome. J Am Coll Cardiol. 2000; 35:771-777.
30. Krapp M, Baschat AA, Gembruch U, Geipel A, Germer U. Flecainide in the intrauterine treatment of fetal supraventricular tachycardia. Ultrasound Obstet Gynecol. 2002;19:158-164.
31. Zielinsky P, Dillenburg RF, de Lima GG, Zimmer LP. Fetal supraventricular tachyarrhythmias. Experience of a fetal cardiology referral center. Arq Bras Cardiol. 1998;70:337-340.
32. Gallik D, Singer I, Meissner M, Molnar J, Somberg J. Hemodynamic and surface electrocardiographic effects of a new aqueous formulation of intravenous amiodarone. Am J Cardiol. 2002;90:964-968.
33. Guccione P, Paul T, Garson A Jr. Long-term follow-up of amiodarone therapy in the young: continued efficacy, unimpaired growth, moderate side effects. J Am Coll Cardiol. 1990;15:1118-1124.
34. Celiker A, Kocak G, Lenk MK, Alehan D, Ozme S. Short- and intermediate-term efficacy of amiodarone in infants and children with cardiac arrhythmia. Turk J Pediatr. 1997;39:219-225.
35. Rotmensch HH, Liron M, Tupilski M, Laniado S. Possible association of pneumonitis with amiodarone therapy. Am Heart J. 1980;100:412-413.
36. Fraire AE, Guntupalli KK, Greenberg D, Cartwright J Jr, Chasen MH. Amiodarone pulmonary toxicity: a multidisciplinary review of current status. South Med J. 1993;86:67-77.
37. Pollak PT. Clinical organ toxicity of antiarrhythmic compounds: ocular and pulmonary manifestations. Am J Cardiol. 1999;84:37R-45R.
38. Garson A, Gillette PC, McVey P, et al. Amiodarone treatment of critical arrhythmias in children and young adults. J Am Coll Cardiol. 1984;4:749-755.
39. Bucknall CA, Keeton BR, Curry PV, Tynan MJ, Sutherland GR, Holt DW. Intravenous and oral amiodarone for arrhythmias in children. Br Heart J. 1986;56:278-284.
40. Keeton BR, Bucknall CA, Curry PV, Joseph MC, Sutherland GR, Holt DW. Use of amiodarone in childhood. Br J Clin Pract Suppl. 1986;44:115-120.
41. Daniels CJ, Schutte DA, Hammond S, Franklin WH. Acute pulmonary toxicity in an infant from intravenous amiodarone. Am J Cardiol. 1997; 80:1113-1116.
42. Bowers PN, Fields J, Schwartz D, Rosenfeld LE, Nehgme R. Amiodarone induced pulmonary fibrosis in infancy. Pacing Clin Electrophysiol. 1998;21:1665-1667.
43. Martin WJ II, Howard DM. Amiodarone-induced lung toxicity. in vitro evidence for the direct toxicity of the drug. Am J Pathol. 1985;120: 344-350.
44. Rokickl W, Durmala J, Nowakowska E. Amiodarone for long term treatment of arrhythmia in children. Wiad Lek. 2001;54:45-50.
45. Kothari SS, Balijepally S, Taneja K. Amiodarone-induced pulmonary toxicity in an adolescent. Cardiol Young. 1999;9:194-196.
46. Martin JW II. Mechanisms of amiodarone pulmonary toxicity. Clin Chest Med. 1990;11:131-138.
47. Lomenick JP, Jackson WA, Backeljauw PF. Amiodarone-induced neonatal hypothyroidism: a unique form of transient early-onset hypothyroidism. J Perinatol. 2004;24:397-399.